therapeutic areas
market launches
Our products cover the full lifecycle of a therapy — from clinical research to market adoption and long-term disease management. Each product is built on the Dawn Platform, ensuring compliance, scalability, and speed.
A solution for generating real-world evidence at scale. By collecting structured, longitudinal data directly from patients, our solution enables pharma to accelerate evidence generation, support regulatory and payer discussions, and gain proprietary insights without relying on third-party aggregators.
Stage
Research & Clinical development
Typical use
Companion app for clinical studies supporting ePRO collection, data consent, and trial participation.
Pharma value
Improves trial retention, enhances data quality, and supports faster regulatory submission.
A patient-facing tool enabling better management of chronic conditions through education, symptom tracking and medication support. These tools drive proactive care, improved outcomes and adherence, all while giving HCPs and pharma ongoing visibility into disease progression and therapy use.
Stage
Pre-prescription & unbranded phase
Typical use
Disease awareness, early education, and support for patients before or around therapy initiation.
Pharma value
Builds early patient engagement, generates insights to guide drug launch strategy, and supports brand readiness.
Case study: Nelia
A companion app for patients living with rare glomerular diseases, Nelia empowers users with education, symptom tracking tools & care coordination.
A digital companion that supports patients during treatment, offering personalized content, reminders and symptom tracking tools. Driving adherence and confidence, we provide pharma with real-world insights, improved patient engagement and differentiation in a competitive market.
Stage
Post-prescription commercial phase
Typical use
Branded treatment support for on-therapy patients, including adherence programs and personalized content.
Pharma value
Improves adherence, strengthens therapy value proposition, and supports lifecycle differentiation.
Our selection of add-on features deliver extended value and differentiation to enhance products even further.
Integrate wearables, injection devices, and passive monitoring tools into a single experience. Connected devices help patients manage their condition at home, while giving healthcare professionals and pharma real-time insights into treatment progress.
Empowering healthcare teams to deliver better, more proactive care and improve patient outcomes. A tool consisting of comprehensive and intuitive dashboards, the portal includes what HCPs really need day-to-day.
– Remote monitoring
– Patient identification support
– Guided patient conversations
– Care coordination tools
– Education and decision support
Our GenAI and advanced algorithms utilize innovation and emerging technology to ensure products deliver patients and HCPs enhanced experiences and connectivity. Our AI chatbot supports patients in the every day and our dosing recommendations and risk stratification algorithms ensure the highest quality of patient care.
Our innovation ecosystem makes it possible to expand any Dawn product with advanced features, device connectivity, and integrations. We bring products to life by orchestrating emerging technologies.
Enhance your product with modular features such as conversational AI chatbots, dosing recommendations, or risk stratification algorithms. These capabilities can be activated on top of any product in the suite to deliver added value and differentiation.
We support a growing set of advanced integrations, including:
Fabric Lakehouse: Unified data platform enabling scalable analytics and AI across all collected data.
Amazon Redshift: High-performance data warehouse supporting clinical trials and real-world evidence analytics.
Amazon S3: Secure, cost-effective storage for raw clinical, genomic, and operational datasets.
We're always exploring new connections to expand our platform's value. Each integration is assessed for technical feasibility, partner maturity, reusability across markets, and commercial value.
Scheduling tools, advanced patient engagement platforms, and new remote monitoring services are all undergoing exploration to expand our ecosystem further.
At Dawn, our approach to Software as a Medical Device (SaMD) balances speed to market with long-term compliance. We help partners launch quickly with products that do not initially require SaMD classification, ensuring that patient needs are validated and market value is proven early. Over time, these products can be enhanced with new features that require SaMD classification, without the need to rebuild the foundation.
Our platform is SaMD-ready. The pre-built capabilities meet regulatory expectations for medical device software, spanning across cybersecurity, risk management, and usability. This structure enables a frictionless evolution from a non-SaMD product to a fully compliant SaMD solution as strategies and products mature.
Iterative innovations without needing to redevelop the core platform
Align with global standards for geographical scalability (ISO, MDR, FDA)
Reduce regulatory risk through a proven SaMD framework
Launch fast and prove real-world need before investing in full SaMD compliance
All our products are developed and maintained under global medical device and data protection standards.
ISO 13485:2016
Quality Management for MD’s
IEC 62304:2006 + AMD1:2015
MD Software Lifecycle Processes
ISO/IEC 27001
Information Security Management
ISO 14971:2019
Application of Risk Management to MD’s
IEC 62366-1:2015+A1:2020
MD Usability
MDR EU 2017/745
MD’s Regulation
IEC 82304-1
Health Software Product Safety
GDPR & HIPAA
EU and US Personal Data & Privacy
Copenhagen
New York
Zürich
